GWM
NVO

GSB Wealth Management’s Novo Nordisk NVO Stock Holding History

GSB Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$904K Sell
24,599
-345
-1% -$16.3K 0.2% 109
2025
Q4 		$1.27M Sell
24,944
-148
-0.6% -$7.57K 0.29% 89
2025
Q3 		$1.39M Buy
25,092
+2,083
+9% +$122K 0.32% 86
2025
Q2 		$1.59M Sell
23,009
-2,185
-9% -$149K 0.39% 80
2025
Q1 		$1.75M Buy
25,194
+800
+3% +$66.1K 0.46% 74
2024
Q4 		$2.1M Buy
24,394
+11,970
+96% +$1.29M 0.54% 64
2024
Q3 		$1.48M Sell
12,424
-1,204
-9% -$161K 0.38% 84
2024
Q2 		$1.95M Buy
13,628
+39
+0.3% +$5.17K 0.53% 65
2024
Q1 		$1.74M Sell
13,589
-634
-4% -$75.5K 0.49% 69
2023
Q4 		$1.47M Buy
14,223
+200
+1% +$19.8K 0.45% 75
2023
Q3 		$1.28M Sell
14,023
-1,323
-9% -$117K 0.43% 79
2023
Q2 		$1.24M Buy
15,346
+580
+4% +$47.4K 0.4% 83
2023
Q1 		$1.17M Sell
14,766
-2,296
-13% -$163K 0.38% 89
2022
Q4 		$1.15M Sell
17,062
-250
-1% -$14.7K 0.41% 89
2022
Q3 		$862K Buy
17,312
+32
+0.2% +$1.71K 0.31% 109
2022
Q2 		$963K Sell
17,280
-5,614
-25% -$312K 0.33% 106
2022
Q1 		$1.27M Sell
22,894
-2,150
-9% -$110K 0.37% 98
2021
Q4 		$1.4M Buy
25,044
+18,288
+271% +$991K 0.4% 88
2021
Q3 		$324K Sell
6,756
-19,640
-74% -$949K 0.17% 115
2021
Q2 		$1.11M Buy
26,396
+134
+0.5% +$5.19K 0.34% 99
2021
Q1 		$885K Buy
26,262
+19,506
+289% +$695K 0.29% 105
2020
Q4 		$236K Hold
6,756
– – 1.06% 42
2020
Q3 		$235K Hold
6,756
– – 1.07% 43
2020
Q2 		$221K Hold
6,756
– – 1.23% 40
2020
Q1 		$203K Buy
+6,756
New +$201K 1.48% 37

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

GSB Wealth Management's NVO Position: Q1 2026 in Review

GSB Wealth Management reduced its Novo Nordisk (NVO) stake by 1.4% in Q1 2026, selling an estimated $16.3K and leaving 24,599 shares worth $904K. The position accounts for 0.2% of the portfolio, ranked #109.

GSB Wealth Management first reported a position in NVO in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.1M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • GSB Wealth Management held 24,599 shares of Novo Nordisk worth $904K as of Q1 2026.
  • GSB Wealth Management sold 345 Novo Nordisk shares in Q1 2026, an estimated $16.3K.
  • Novo Nordisk made up 0.2% of GSB Wealth Management's portfolio in Q1 2026, its #109 holding.
  • GSB Wealth Management first reported a position in Novo Nordisk in Q1 2020 and has held it in 25 quarters since.
  • GSB Wealth Management's Novo Nordisk position peaked at $2.1M in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on GSB Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.